Using Local Microbiologic Data To Develop Institution-Specific Guidelines for the Treatment of Hospital-Acquired Pneumonia
- 1 September 2006
- Vol. 130 (3) , 787-793
- https://doi.org/10.1378/chest.130.3.787
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Impact of Clinical Guidelines in the Management of Severe Hospital-Acquired PneumoniaChest, 2005
- Effect of Aminoglycoside and β‐Lactam Combination Therapy versus β‐Lactam Monotherapy on the Emergence of Antimicrobial Resistance: A Meta‐analysis of Randomized, Controlled TrialsClinical Infectious Diseases, 2005
- Guidelines for the Management of Adults with Hospital-acquired, Ventilator-associated, and Healthcare-associated PneumoniaAmerican Journal of Respiratory and Critical Care Medicine, 2005
- National Nosocomial Infections Surveillance (NNIS) System Report, data summary from January 1992 through June 2004, issued October 2004American Journal of Infection Control, 2004
- β lactam monotherapy versus β lactam-aminoglycoside combination therapy for sepsis in immunocompetent patients: systematic review and meta-analysis of randomised trialsBMJ, 2004
- Hospital-acquired pneumonia in general wards of a Japanese tertiary hospitalRespirology, 2004
- Appropriate use of antimicrobial agents: Challenges and strategies for improvementCritical Care Medicine, 2003
- Inadequate Antimicrobial Treatment: An Important Determinant of Outcome for Hospitalized PatientsClinical Infectious Diseases, 2000
- Impact of BAL Data on the Therapy and Outcome of Ventilator-Associated PneumoniaChest, 1997
- Modification of empiric antibiotic treatment in patients with pneumonia acquired in the intensive care unitIntensive Care Medicine, 1996